Clinical Trial Update: A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics and safety of JNJ-64565111 in adults with varying degrees of renal function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• JNJ-64565111

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Kidney Failure, Chronic | Phase 1 | Status: COMPLETED